Alligator Bioscience
0,42SEK +0,72%1 investor følger denne virksomhed
Alligator Bioscience is a research-based biotechnology company that uses patented technology to develop biological drug candidates in inflammation and cancer. The company is active in the former part of the drug development chain. Alligator Bioscience has a global technology platform and is active in a rapidly growing segment of the pharmaceutical market - protein drugs. The company was founded in 2001 and is headquartered in Lund, Sweden.
Omsætning
35,7 mio.
EBIT %
-540,03 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
ATORX
Daglig lav / høj pris
0,416 / 0,445
SEK
Markedsværdi
276,34 mio. SEK
Aktieomsætning
54,76 t SEK
Volumen
131 t
Seneste videoer
Finanskalender
Årsrapport
15.02.2024
Delårsrapport
25.04.2024
Generalforsamling
07.05.2024
Major OwnersSource: Millistream Market Data AB
| Owner | Capital | Votes |
|---|---|---|
| Allegro Investment | 31,2 % | 31,3 % |
| Roxette Photo | 8,1 % | 8,1 % |
Premium
Not activated
This content is for our Premium customers only.
ViserAlle indholdstyper